Latest news
Lilly beats estimates on resilient demand for injectable GLP-1 drugs, widens gap with Novo - The Mighty 790 KFGOThe Mighty 790 KFGO · Wed, 05 Aug 2026 07:00:00 GMTNovo CEO looks to speed up R&D as share drop shows gap with Lilly - The Mighty 790 KFGOThe Mighty 790 KFGO · Wed, 05 Aug 2026 06:37:03 GMTEli Lilly to offer early access to next-gen obesity drug to some patients - The Mighty 790 KFGOThe Mighty 790 KFGO · Mon, 03 Aug 2026 22:56:59 GMTAnalysis-Obesity battle heats up again as Novo claws way back into race with Lilly - The Mighty 790 KFGOThe Mighty 790 KFGO · Mon, 03 Aug 2026 05:21:05 GMTLilly, Resilience to invest $750 million in US drug manufacturing expansion - The Mighty 790 KFGOThe Mighty 790 KFGO · Thu, 30 Jul 2026 13:20:42 GMT